Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath Sells 108 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Jamie Samath also recently made the following trade(s):

• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.89, for a total value of $145,230.41.

Intuitive Surgical Stock Down 0.7 %

Intuitive Surgical stock opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $304.50 and a 12-month high of $552.00. The firm’s fifty day moving average is $507.94 and its 200 day moving average is $466.79. The company has a market capitalization of $191.82 billion, a PE ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Raymond James increased their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Piper Sandler restated an “overweight” rating and issued a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $526.06.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Peapack Gladstone Financial Corp increased its stake in Intuitive Surgical by 1.3% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 13,085 shares of the medical equipment provider’s stock valued at $6,427,000 after purchasing an additional 167 shares in the last quarter. Synovus Financial Corp grew its stake in shares of Intuitive Surgical by 1.1% in the 3rd quarter. Synovus Financial Corp now owns 2,572 shares of the medical equipment provider’s stock worth $1,264,000 after acquiring an additional 28 shares in the last quarter. Destination Wealth Management grew its stake in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Destination Wealth Management now owns 770 shares of the medical equipment provider’s stock worth $378,000 after acquiring an additional 30 shares in the last quarter. Wilmington Savings Fund Society FSB grew its stake in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, Arvest Bank Trust Division bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth $260,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.